• flanders.bio has relocated!

    Monday September 5th 2022

  • Nieuwe investering voor HERAN Partners: Aspect Analytics

    Monday September 5th 2022

  • Pathomation announces new release of the “My Pathomation” cloud platform for digital pathology

    Friday September 2nd 2022

  • Biocartis initiates commercialization in Europe of SkylineDx’s innovative Merlin™ Assay (CE-IVD) for melanoma patients

    Thursday September 1st 2022

  • reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration

    Wednesday August 31st 2022

  • Autoimmune disorders increase risk of cardiovascular disease

    Saturday August 27th 2022

  • Biocartis obtains ISO 27001 certification for information security management

    Thursday August 25th 2022

  • Alexandra Clyde appointed to Sequana Medical Board of Directors

    Thursday August 25th 2022

  • Your news here?

  • KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

    Thursday August 25th 2022

  • mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers investing in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA

    Tuesday August 23rd 2022

  • argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis

    Thursday August 11th 2022

Strategic Partners